GBLX
GB Sciences, Inc.
1W: +50.0%
1M: +0.0%
3M: -40.0%
YTD: -40.0%
1Y: +0.0%
3Y: -98.3%
5Y: -99.5%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.1M
52W Range0.0001-0.50015
Volume10,000
Avg Volume54,964
Beta9.86
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOAndrea Small-Howard
Employees2
SectorHealthcare
IndustryBiotechnology
IPO Date2008-05-12
Websitegbsciences.com
3550 West Teco Avenue
Las Vegas, NV 89118
US
Las Vegas, NV 89118
US
866 721 0297
About GB Sciences, Inc.
GB Sciences, Inc. engages in the research and development of plant-based medicines in North America and Europe. The company offers cannabinoid-inspired medicines and complex therapeutic mixtures for the prescription drug market. Its intellectual property covers a range of conditions and programs in pre-clinical animal stage for Parkinson's disease, neuropathic pain, chronic pain, COVID-related cytokine release syndrome, depression/anxiety, and cardiovascular therapeutic programs. The company was formerly known as Growblox Sciences, Inc. and changed its name to GB Sciences, Inc. in October 2016. GB Sciences, Inc. was incorporated in 2001 and is based in Las Vegas, Nevada.
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| POSS JOHN C | P-Purchase | 3,615 | $0.41 | 2018-07-11 |
| POSS JOHN C | P-Purchase | 11,915 | $0.41 | 2018-07-11 |
| POSS JOHN C | P-Purchase | 20,000 | $0.41 | 2018-07-11 |
| POSS JOHN C | P-Purchase | 1,250 | $0.41 | 2018-07-11 |
| POSS JOHN C | P-Purchase | 30,000 | $0.41 | 2018-07-11 |